NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $258,135 | +0.9% | 2,534 | 0.0% | 0.06% | +3.2% |
Q2 2023 | $255,728 | +9.7% | 2,534 | 0.0% | 0.06% | +6.9% |
Q1 2023 | $233,148 | +2.6% | 2,534 | +1.2% | 0.06% | -14.7% |
Q4 2022 | $227,321 | +5.7% | 2,505 | -1.5% | 0.07% | -12.8% |
Q2 2022 | $215,000 | -4.9% | 2,544 | -1.2% | 0.08% | -11.4% |
Q1 2022 | $226,000 | +2.3% | 2,574 | +2.0% | 0.09% | +2.3% |
Q4 2021 | $221,000 | – | 2,524 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |